AbCellera
About
AbCellera is a technology company that partners with drug developers to discover and develop antibody therapeutics. Their AI-powered drug discovery platform integrates high-throughput screening, genomics, and AI to accelerate the identification of therapeutic antibodies from natural immune responses.
Key facts
At-a-glance profile data
- Website
- abcellera.com
- Headquarters
- Vancouver, Canada
- Founded
- 2012
- Total funding
- $10M (Public Offering)
- Business model
- B2B
Funding rounds
| Date | Round | Amount | Lead investors |
|---|---|---|---|
| 11 Aug 2026 | Public Offering | Undisclosed | - |
| 24 May 2018 | Series A | $10M | DCVC |
Tech stack
Detected on abcellera.com, last scanned 24 Sept 2026. Run your own scan
- Analytics
- Google Tag Manager
- CMS / Builders
- Webflow
- CDN
- Cloudflare
- Email provider
- Google Workspace
- Status page
- Statuspage
Add first review
Frequently asked
How much funding has AbCellera raised?
AbCellera has raised a total of $10M in funding. The most recent round on record is Public Offering.